VetMedGuide

Vet Med Guide

Companion animal in a veterinary exam setting with medication reference materials.
Pharmaceuticals2026-05-23 · 11 min read

Feline Hypertension: Blood Pressure Screening, Target Organ Damage

Systemic hypertension in cats is underdiagnosed until it causes blindness or kidney damage.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

On April 29, 2026, the FDA approved Amodip (amlodipine besylate chewable tablets), the first FDA-approved amlodipine product for veterinary use and only the second FDA-approved drug for controlling systemic hypertension in cats. The approval highlights something many cat owners and even some veterinary teams underestimate: feline hypertension is common, it is underdiagnosed, and when it is caught late, the damage is often irreversible.

This article covers how feline hypertension develops, what target organ damage looks like, how blood pressure is measured and staged, what treatment options exist (including the newly approved Amodip), and what cat owners should know about monitoring.

How common is hypertension in cats

Systemic hypertension in cats is most often a secondary condition — it develops as a complication of another disease. The two most common underlying causes are chronic kidney disease (CKD) and hyperthyroidism. Because both of those diseases become more prevalent with age, hypertension is primarily a disease of older cats.

Data from clinical studies show:

  • Approximately 60–65% of hypertensive cats have concurrent CKD.
  • 20–30% of hyperthyroid cats have systemic hypertension, which may persist even after the thyroid disease is treated.
  • Idiopathic hypertension (no identifiable underlying cause) accounts for roughly 20–30% of cases.
  • The prevalence increases sharply with age. Cats over 12 years old should have blood pressure screened routinely.

A study published in the Journal of Veterinary Internal Medicine found that 87% of hypertensive cats had either cardiac or ocular abnormalities at the time of first diagnosis, suggesting that most hypertension is not being caught early.

Target organ damage: the real risk

Hypertension in cats is not treated because of a number on a screen. It is treated because sustained high blood pressure damages four organ systems — the eyes, kidneys, heart, and brain. This is called target organ damage (TOD), and it is often the reason the cat is brought to the veterinarian in the first place.

Eyes: Hypertensive retinopathy is the most visible consequence. Sustained systolic blood pressure above 160–180 mmHg can cause retinal detachment, retinal hemorrhage, and hyphema (blood in the anterior chamber). The presenting sign is often acute blindness — sudden onset, not gradual. In a study of 80 hypertensive cats in Japan, 25 had ocular target organ damage. Once the retina detaches, the prognosis for vision recovery depends on how quickly blood pressure is controlled. Some cats regain partial vision; many do not.

Kidneys: Hypertension both results from CKD and accelerates it. A controlled study of over 200 cats demonstrated increased glomerulosclerosis and arteriosclerosis in cats with higher blood pressure. Treating hypertension in CKD cats reduces proteinuria, which has been linked to improved survival. The relationship between hypertension and kidney disease is bidirectional: each makes the other worse.

Heart: Left ventricular hypertrophy and gallop rhythms are common echocardiographic findings in hypertensive cats. These changes reflect the heart working against elevated systemic resistance over time. While the cardiac changes themselves may not cause acute symptoms, they contribute to overall cardiovascular risk.

Brain and nervous system: Neurologic signs — disorientation, seizures, ataxia, and behavioral changes — can occur with severely elevated blood pressure. In the Japanese study, 6 of 80 hypertensive cats had documented neurologic target organ damage.

Blood pressure measurement in cats

Measuring blood pressure in a cat is straightforward technically but challenging practically. Cats are easily stressed by handling, unfamiliar environments, and the measurement process itself, which can falsely elevate readings.

Methods

Two techniques are commonly used in veterinary practice:

Doppler ultrasound: A crystal sensor placed over a peripheral artery (typically the palmar metatarsal artery on the hindlimb) detects blood flow. A cuff is inflated proximally, and the pressure at which flow returns is the systolic blood pressure. Doppler is widely considered the most reliable method for cats. It provides systolic pressure only (not diastolic), but systolic pressure is the primary treatment target in feline medicine.

Oscillometric: Automated devices that detect oscillations in the cuff pressure as the artery pulsates. These devices provide both systolic and diastolic readings but are more sensitive to motion artifact and may underperform in small or anxious cats. High-definition oscillometric (HDO) devices have shown improved accuracy in feline patients.

Technique matters

The ACVIM consensus guidelines on systemic hypertension in dogs and cats emphasize standardized technique:

  • Allow the cat to acclimate to the room for 5–10 minutes before measurement.
  • Use a quiet room with minimal stimulation.
  • Position the cat in sternal recumbency or a natural resting position.
  • Use an appropriately sized cuff (width approximately 40% of limb circumference).
  • Take 5–7 readings, discard the first, and average the remaining.
  • Consistent cuff placement site across visits for serial comparison.

A single elevated reading does not diagnose hypertension. The ACVIM guidelines recommend confirming elevated blood pressure on at least two separate visits before initiating treatment, unless target organ damage is already present.

Blood pressure staging (ACVIM classification)

Category Systolic BP (mmHg) Risk of TOD Recommended action
Normotensive < 140 Minimal Routine monitoring
Prehypertensive 140–159 Low Monitor every 3 months; screen for underlying disease
Hypertensive 160–179 Moderate Treat if TOD present or confirmed on repeat measurement
Severely hypertensive ≥ 180 High Treat immediately; screen for TOD

Treatment

The goal of treatment is to reduce systolic blood pressure below 160 mmHg to minimize the risk of target organ damage. Treatment is usually lifelong.

Amlodipine (first-line therapy)

Amlodipine besylate, a calcium channel blocker that acts on vascular smooth muscle, is the most widely used antihypertensive drug in feline medicine and is considered first-line by the ACVIM, ISFM, and FelineVMA (formerly AAFP).

The FDA approval of Amodip (April 2026): Prior to the Amodip approval, veterinarians prescribed amlodipine to cats as an off-label use of the human generic drug — typically by splitting 2.5 mg or 5 mg human tablets. This created dosing inconsistency (crushed tablets, uneven halves) and owner compliance challenges.

Amodip is the first FDA-approved amlodipine specifically for cats. Key details from the FDA announcement:

  • Indicated for the control of systemic hypertension in cats.
  • Available as chewable tablets, which addresses the compliance problem of splitting human tablets.
  • Prescribing veterinarians should monitor blood pressure regularly and adjust dose as needed.
  • Bloodwork should be monitored early in treatment for potential changes in kidney and liver values.
  • Owners should monitor for side effects: decreased appetite, vomiting, and diarrhea.

The ISFM consensus guidelines recommend starting amlodipine at 0.625 mg per cat once daily (approximately 0.125 mg/kg), with dose increases to 1.25 mg per cat if blood pressure remains above 160 mmHg after 10–14 days. In severely hypertensive cats (systolic BP > 200 mmHg) with active target organ damage, a loading dose of up to 2.5 mg in the first 24 hours may be used under close monitoring.

In clinical studies, most cats achieve blood pressure below 160 mmHg on amlodipine monotherapy. A study of 100 hypertensive cats found that the dose required varied by individual, reinforcing the importance of regular recheck measurements and dose titration.

Telmisartan

Telmisartan is an angiotensin receptor blocker (ARB) licensed in some regions for managing CKD-associated proteinuria in cats. It has antihypertensive properties and may be used alongside or instead of amlodipine in cats that remain hypertensive despite amlodipine monotherapy, particularly those with concurrent proteinuria.

One study showed telmisartan produced a greater blood pressure reduction than benazepril in response to angiotensin I-induced pressor response at doses of 1–3 mg/kg.

Benazepril and other ACE inhibitors

Benazepril and other ACE inhibitors (enalapril, ramipril) are used in cats with CKD and proteinuria but are generally less effective as antihypertensive monotherapy than amlodipine. They may be added as combination therapy when amlodipine alone does not achieve target blood pressure.

Atenolol

Atenolol is a beta-blocker used in cats with hypertension secondary to hyperthyroidism, where the increased heart rate and cardiac output contribute to elevated blood pressure. It is not typically first-line for idiopathic or CKD-associated hypertension.

Combination therapy

Some cats — particularly those with severe hypertension and multiple target organ complications — require combination therapy. A published case report described an 11-year-old cat with idiopathic hypertension and bilateral retinal detachment treated successfully with a combination of amlodipine, telmisartan, and atenolol. Combination therapy requires careful monitoring because additive blood pressure reduction can cause hypotension.

Monitoring

Once antihypertensive therapy is initiated, monitoring should include:

  • Blood pressure recheck 1–2 weeks after starting or adjusting medication. The goal is systolic BP below 160 mmHg.
  • Blood pressure monitoring every 3–4 months once stable, or more frequently if the underlying disease is progressing.
  • Bloodwork (creatinine, SDMA, BUN, UPC ratio, thyroid panel) every 3–6 months to track the underlying disease and detect medication-related changes in kidney or liver values.
  • Ophthalmic examination at diagnosis and periodically to assess for ongoing or resolving retinal damage.
  • Echocardiogram if cardiac target organ damage is suspected.

The frequency of monitoring depends on disease severity. The ACVIM guidelines recommend that cats with severe hypertension (systolic BP ≥ 180 mmHg) have blood pressure rechecked twice over a 2-week period after initiating treatment, while cats with moderate hypertension (160–179 mmHg) can be rechecked over an 8-week window.

When to screen

Because feline hypertension is usually secondary and often asymptomatic until target organ damage occurs, screening is recommended for:

  • All cats over 12 years of age, at every veterinary visit.
  • Cats diagnosed with CKD, at diagnosis and every 3–6 months thereafter.
  • Cats diagnosed with hyperthyroidism, before and after treatment initiation.
  • Cats presenting with acute blindness, retinal changes, or neurologic signs.
  • Cats with a heart murmur or echocardiographic evidence of left ventricular hypertrophy where hypertension has not been excluded.

The FelineVMA Hypertension Toolkit recommends that blood pressure measurement become a routine part of the senior cat wellness examination, similar to how blood pressure is checked in older human patients.

What cat owners should ask

If your cat has been diagnosed with hypertension, or if your veterinarian has recommended blood pressure screening, these questions help clarify the plan:

  • "What was the systolic blood pressure reading, and how does that compare to the treatment threshold?"
  • "Is there evidence of target organ damage — changes in the eyes, kidneys, or heart?"
  • "What underlying disease might be causing the high blood pressure? Has my cat been screened for kidney disease and hyperthyroidism?"
  • "What medication are you starting, and how soon should we recheck the blood pressure?"
  • "What side effects should I watch for at home?"
  • "How often will my cat need blood pressure checks and bloodwork going forward?"

Sources

Topics
Feline CKDCardiology
Related Articles